|
|
| Catalog Number |
1201520 |
| Medical Device Problem Code |
Patient-Device Incompatibility (2682)
|
| Health Effect - Clinical Code |
Abscess (1690)
|
| Date of Event |
06/28/2018
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
As reported, post-implant of the phasix st mesh, the patient was diagnosed with abdominal wall abscess, treated with iv antibiotics and underwent reoperation.As reported, the ae is resolved.The clinician has assessed the patient¿s postoperative course as being possibly related to the study device and definitely related to the procedure, however, based on the information provided, no conclusion can be made.Review of manufacturing records shows product was manufactured to specification.This mdr reports the adverse event of abdominal wall abscess.An additional mdr has been submitted to report the additional adverse event of abdominal wall cellulitis and sepsis.Remains implanted.
|
| |
|
Event or Problem Description
|
|
Reported per clinical trial (b)(4): (b)(6) 2018 - subject patient underwent a robotic-assisted multiple recurrent midline ventral hernia (12 cm x 13 cm) repair procedure.Swiss cheese configuration noted.A bard/davol phasix st mesh was placed midline in an underlay fashion and fixated using sutures.Complete fascia closure could not be achieved due to poor quality fascia and full skin closure was achieved using adhesive skin closure and the subject patient was discharged to home on (b)(6) 2018.(b)(6) 2018 - subject patient presented with worsening abdominal pain and tenderness at the ileo conduit ureterostomy site.Subject patient was admitted to the hospital and was diagnosed with abdominal wall cellulitis at the site.(b)(6) 2018 - subject patient was diagnosed with sepsis.Subject patient underwent incision and drainage at bed side, urostomy bag replaced to decrease leaking and patient was treated with iv antibiotics.The subject patient was discharged to home on (b)(6) 2018.Per the study clinician, the reported adverse event of abdominal wall cellulitis is assessed to be moderate in severity, possibly related to the study device and definitely related to the index procedure.The outcome for this ae is reported as recovered/resolved.The reported adverse event of sepsis is assessed as severe, possibly related to the study device and possibly related to the index procedure.The outcome for this ae is reported as recovered/resolved.(b)(6) 2018 - subject patient was diagnosed with abdominal wall abscess and was admitted to the hospital.The patient was treated with iv antibiotics and was discharged on (b)(6) 2018.(b)(6) 2018 - subject patient underwent reoperation for the abdominal wall abscess.Per the study clinician, the reported adverse event (abdominal wall abscess) is moderate in severity, possibly related to the study device and definitely related to the index procedure.The outcome for this ae is reported as recovered/resolved.
|
| |
|
Search Alerts/Recalls
|
|
|